NCT06360120View on ClinicalTrials.gov

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

September 10, 2025

Study Completion Date

October 1, 2025

Conditions
Ischemic Stroke
Interventions
DRUG

Atorvastatin 40 Mg Oral Tablet

The atorvastatin group consisted of 300 patients who received 40 mg daily atorvastatin for 3 months, and open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.

DRUG

Rosuvastatin 20mg

The rosuvastatin group consisted of 300 patients who received 40 mg daily rosuvastatin for 3 months, and open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.

DRUG

Clopidogrel 75 Mg Oral Tablet

open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.

DRUG

Clopidogrel 75 Mg Oral Tablet

open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.

Trial Locations (1)

33511

RECRUITING

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER